CV / English / Pharmacovigilance Scientist
Personal Information
- Name: Daniel Sterling
- Address: 485 Sunshine Ave, Medville, CA 23456
- Email: [email protected]
- Phone: (555) 123-4567
Professional Profile
A dedicated and detail-oriented Pharmacovigilance Scientist with over 5 years of experience in the pharmaceutical industry. Skilled at assessing and reporting on the safety profiles of pharmaceutical products, with a strong foundation in both pre- and post-market drug safety studies. Adept at working with cross-functional teams to monitor, evaluate, and ensure compliance with global regulatory standards.
Core Competencies
- Drug Safety and Pharmacovigilance
- Regulatory Compliance
- Adverse Event Reporting Systems (AERS)
- Risk Management
- Clinical Trial Monitoring
- Data Analysis & Reporting
- Cross-functional Team Collaboration
Technologies & Certifications
- Certifications: Certified Drug Safety Specialist (CDSS)
- Software Proficiency: Argus Database, Veeva Vault Safety, Microsoft Office Suite
- Data Analysis Tools: SAS, SPSS
Professional Experience
Senior Pharmacovigilance Scientist, NexPharma Inc., Medville, CA
April 2019 - Present
- Led a team to implement new drug safety monitoring protocols, which reduced adverse event report processing time by 30%.
- Collaborated with regulatory affairs to ensure compliance with FDA and EMA guidelines for pharmacovigilance.
- Played a key role in the post-market surveillance of three major drug releases, identifying critical safety concerns that led to swift regulatory action.
Pharmacovigilance Associate, WellPharm Co., San Francisco, CA
July 2017 - March 2019
- Analyzed and processed over 10,000 adverse event reports, improving data accuracy by 25%.
- Assisted in the development of risk management plans for several high-profile drug launches.
- Coordinated with research teams to facilitate phase IV clinical trials, ensuring optimal patient safety.
Education & Training
M.S. in Pharmacy, Focus on Pharmacovigilance & Drug Safety University of California, San Francisco, 2017
B.S. in Biological Sciences University of California, Davis, 2015
Referees
Dr. Emily Hartwell Senior Research Scientist, NexPharma Inc. Email: [email protected] Phone: (555) 234-5678
Mr. Thomas Guerrero Director of Regulatory Affairs, WellPharm Co. Email: [email protected] Phone: (555) 345-6789